TENAX THERAPEUTICS, INC. (TENX) › Shareholders' EquityTENAX THERAPEUTICS, INC. (TENX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2010: $2.13M2011: -$3.72M2012: -$346.0K2013: -$1.78M2014: $82.86M2015: $60.42M2016: $17.14M2017: $8.88M2018: $11.77M2019: $3.77M2020: $4.63M2021: $4.24M2022: $1.49M2023: $8.10M2024: $91.99M2025: $97.07M$97.07M2010Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$97.07M+5.5%2024$91.99M+1036.0%2023$8.10M+442.4%2022$1.49M-64.8%2021$4.24M-8.2%2020$4.63M+22.6%2019$3.77M-68.0%2018$11.77M+32.5%2017$8.88M-48.2%2016$17.14M-71.6%2015$60.42M-27.1%2014$82.86M+4759.9%2013-$1.78M-413.8%2012-$346.0K+90.7%2011-$3.72M-275.1%2010$2.13M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share